Delivery Order SPE2DB20D3103-SPE2DB24FP6C9

Award Date 7/22/24
Potential Completion Date 8/12/24
Potential Value $1.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, Corporate Office Division. The $1,387.50 firm fixed price delivery order is for the supply of 4565217636 RHOPHYLAC 300 MCG/2 ML SYRINGE 2ML, a pharmaceutical product. The contract has an ultimate completion date of August 9, 2024. Amerisourcebergen, a major pharmaceutical distributor, has been awarded this task order under a larger Indefinite Delivery Contract...
This federal contract award is for the delivery of the pharmaceutical product RHOPHYLAC 300 MCG/2 ML SYRINGE 2ML to the Defense Logistics Agency (DLA). The $2,775.00 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government. The contract has an ultimate completion date of August 5, 2024. Amerisourcebergen holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of RHOPHYLAC 300 MCG/2 ML SYRINGE 2ML, a medical product. The contract, valued at $1,380.52, was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a division of the Department of Defense (DoD). The contract has an ultimate completion date of August 14, 2024, and is structured as a Firm Fixed Price Delivery Order. Amerisourcebergen is a well-established federal...
This federal contract award is for the delivery of RHOPHYLAC 300 MCG/2 ML SYRINGE 2ML, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The $2,295.05 fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on July 26, 2024, with a completion date of August 16, 2024. The contract is not designated with a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,390.00 firm fixed-price contract is for the supply of 4567321981 ! RHOPHYLAC 300 MCG/2 ML SYRINGE 2ML, a medical product used for healthcare purposes. The contract has an ultimate completion date of March 13, 2025. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award to Amerisourcebergen Drug Corp is a Delivery Order valued at $1,434.00 for the pharmaceutical product RHOPHYLAC 150MCG/ML 2S. The contract is with the Defense Logistics Agency (DLA), which is the Department of Defense's combat logistics support agency, and has a completion date of June 12, 2025. The contract is a Firm Fixed Price arrangement and is not set aside for any special categories of contractors. Amerisourcebergen Drug Corp is a major pharmaceutical...
This is a federal contract award issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,434.00, is a Delivery Order with a Firm Fixed Price pricing type and an ultimate completion date of March 7, 2025. The contract is for the supply of RHOPHYLAC 300 MCG/2 ML SYRINGE 2ML, which is a medical product used for healthcare purposes. The award is not designated with a set-aside,...
This is a federal delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the delivery of RHOPHYLAC 300 MCG/2 ML SYRINGE 2ML, a medical product, with a total ceiling value of $1,625.20. The contract is a firm fixed-price, non-set-aside award with an ultimate completion date of June 11, 2025. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,836.04 firm fixed price contract is for the supply of RHOPHYLAC, a 300 mcg/2 mL syringe medication, with an ultimate completion date of October 15, 2024. The award does not utilize a set-aside designation. AmerisourceBergen holds multiple Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies, collectively valued up to...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of RHOPHYLAC 300 MCG/2 ML SYRINGE 2ML. The contract has a firm fixed price of $1,377.03 and an ultimate completion date of August 19, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for providing a...
  • SPE2DB20D3103
    Indefinite Delivery Contract
  • SPE2DB20D3103-SPE2DB24FP6C9
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a delivery order under an Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $1,387.50, is for the supply of RHOPHYLAC 300 MCG/2 ML SYRINGE 2ML, a specialty pharmaceutical product. The contract is a firm fixed-price arrangement with a period of performance through August 2024. This award is associated with a larger $999,999,999 IDC held by Amerisourcebergen with the DLA, which provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition. As a key vendor for federal healthcare programs, particularly within military and veterans' healthcare systems, Amerisourcebergen plays a critical role in supplying essential medical commodities to the U.S. government.

Generated 2/27/25, 10:57 AM